GLMD Stock Summary and Trading Ideas (Galmed Pharmaceuticals Ltd. - | NASDAQ:GLMD)

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Galmed Pharmaceuticals Ltd. - trades on the NASDAQ stock market under the symbol GLMD.

As of December 31, 2025, GLMD stock price was flat at $0.75 with 85,455 million shares trading.

GLMD has a beta of 1.73, meaning it tends to be more sensitive to market movements. GLMD has a correlation of 0.11 to the broad based SPY ETF.

GLMD has a market cap of $4.11 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, GLMD traded as high as $170.10 and as low as $.73.

GLMD has underperformed the market in the last year with a price return of -75.9% while the SPY ETF gained +17.2%. GLMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -45.6% and -23.4%, respectively, while the SPY returned +2.7% and +0.7%, respectively.

GLMD support price is $.71 and resistance is $.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GLMD shares will trade within this expected range on the day.